Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn 60.62%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.62%
Dec 31, 2025 92.38%
Sep 30, 2025 16.77%
Jun 30, 2025 57.90%
Mar 31, 2025 -47.40%
Dec 31, 2024 -31.44%
Sep 30, 2024 5.09%
Jun 30, 2024 15.18%
Mar 31, 2024 40.89%
Dec 31, 2023 -213.99%
Sep 30, 2023 -169.29%
Jun 30, 2023 -1,684.01%
Mar 31, 2023 -1,266.32%
Dec 31, 2022 78.48%
Sep 30, 2022 -393.60%
Jun 30, 2022 2.85%
Mar 31, 2022 23.31%
Dec 31, 2021 -249.88%
Sep 30, 2021 -146.65%
Jun 30, 2021 113.14%
Mar 31, 2021 -122.66%
Dec 31, 2020 -180.25%
Sep 30, 2020 111.49%
Jun 30, 2020 -3,268.19%
Mar 31, 2020 2,761.20%
Dec 31, 2019 31.73%
Sep 30, 2019 -3,244.18%
Jun 30, 2019 -159.14%
Mar 31, 2019 -82.84%
Dec 31, 2018 485.16%
Sep 30, 2018 -135.04%
Jun 30, 2018 -75.99%
Mar 31, 2018 326.43%
Dec 31, 2017 146.85%
Sep 30, 2017 -66.72%
Jun 30, 2017 151.76%
Mar 31, 2017 -160.10%
Dec 31, 2016 -253.66%
Sep 30, 2016 1,417.77%
Jun 30, 2016 -282.59%
Mar 31, 2016 149.63%
Dec 31, 2015 141.38%
Sep 30, 2015 -2,914.29%
Jun 30, 2015 696.93%
Mar 31, 2015 -208.49%
Dec 31, 2014 51.11%
Sep 30, 2014 100.15%
Jun 30, 2014 77.32%
Mar 31, 2014 -172.76%
Dec 31, 2013 -159.44%
Sep 30, 2013 -302.28%
Jun 30, 2013 -126.36%
Mar 31, 2013 -49.83%
Dec 31, 2012 128.93%
Sep 30, 2012 -17.59%
Jun 30, 2012 73.60%
Mar 31, 2012 116.46%
Dec 31, 2011 245.84%
Sep 30, 2011 32.63%
Jun 30, 2011 -35.70%